TP53 and mutations in human cancer.

作者: Katarzyna Szymańska , Pierre Hainaut

DOI: 10.18388/ABP.2003_3731

关键词: CancerCarcinogenGeneticsMutationGeneMissense mutationMutagenBiologyMutagenesis (molecular biology technique)Hepatocellular carcinoma

摘要: TP53 is the most frequently mutated gene in human cancer, with a predominance of missense mutations scattered over 200 codons. In many cancers, specific mutation patterns can be identified, which are shaped by site-specific mutagenesis and biological selection. tobacco-related cancers (lung, head neck), organ-specific observed, compatible ones experimentally induced tobacco carcinogens. several other such as squamous cell carcinoma oesophagus or hepatocellular (HCC), show geographic variations between regions high low incidence, suggesting role for region-specific risk factors. HCC from high-incidence showing also prevalence Ser-249 one striking examples mutagen fingerprint. All assessments useful to generate clues on mutagenic mechanisms involved cancer. Moreover, it has been shown that DNA retrieved plasma successfully used detection mutations, gives hope earlier more accurate cancers.

参考文章(21)
Philippe Anker, Hugh Mulcahy, Xu Qi Chen, Maurice Stroun, Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer and Metastasis Reviews. ,vol. 18, pp. 65- 73 ,(1999) , 10.1023/A:1006260319913
E Appella, C W Anderson, Signaling to p53: breaking the posttranslational modification code. Pathologie Biologie. ,vol. 48, pp. 227- 245 ,(2000)
M S Greenblatt, W P Bennett, M Hollstein, C C Harris, Mutations in the p53 Tumor Suppressor Gene: Clues to Cancer Etiology and Molecular Pathogenesis Cancer Research. ,vol. 54, pp. 4855- 4878 ,(1994)
Stefan Ambs, Mofolusara O. Ogunfusika, Emanuela Felley-Bosco, William P. Bennett, Curtis C. Harris, William G. Merriam, Peter G. Shields, Timothy R. Billiar, Shawn Klein, Sean M. Oser, Frequent Nitric Oxide Synthase-2 Expression in Human Colon Adenomas: Implication for Tumor Angiogenesis and Colon Cancer Progression Cancer Research. ,vol. 58, pp. 334- 341 ,(1998)
Pierre Hainaut, Monica Hollstein, p53 and Human Cancer: The First Ten Thousand Mutations Advances in Cancer Research. ,vol. 77, pp. 81- 137 ,(1999) , 10.1016/S0065-230X(08)60785-X
Charles J. Sherr, The Pezcoller lecture: cancer cell cycles revisited. Cancer Research. ,vol. 60, pp. 3689- 3695 ,(2000)
Leela Daya-Grosjean, Nicolas Dumaz, Alain Sarasin, The specificity of p53 mutation spectra in sunlight induced human cancers Journal of Photochemistry and Photobiology B: Biology. ,vol. 28, pp. 115- 124 ,(1995) , 10.1016/1011-1344(95)07130-T
Gerd P Pfeifer, Mikhail F Denissenko, Magali Olivier, Natalia Tretyakova, Stephen S Hecht, Pierre Hainaut, Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers Oncogene. ,vol. 21, pp. 7435- 7451 ,(2002) , 10.1038/SJ.ONC.1205803
W. Rideout, G. Coetzee, A. Olumi, P. Jones, 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science. ,vol. 249, pp. 1288- 1290 ,(1990) , 10.1126/SCIENCE.1697983
Magali Olivier, Ros Eeles, Monica Hollstein, Mohammed A. Khan, Curtis C. Harris, Pierre Hainaut, The IARC TP53 database: new online mutation analysis and recommendations to users. Human Mutation. ,vol. 19, pp. 607- 614 ,(2002) , 10.1002/HUMU.10081